Linear IgA bullous dermatosis is a rare immune-mediated vesiculobullous disease [2, 3].
Drug-induced linear IgA bullous dermatosis is a rarer subclassification of the disease.
The first case of vancomycin-induced linear IgA bullous dermatosis was reported in 1988 [5,6].
Due to heterogeneous clinical features, linear IgA bullous dermatosis must be differentiated from a number of diseases including pemphigus vulgaris, bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme .
(93.) Onodera H, Mihm MC Jr, Yoshida A, Akasaka T: Drug-induced linear IgA bullous dermatosis. J Dermatol 2005;32:759-64.
(94.) Van der Waal Rl, van de Scheur MR, Pas HH, Jonkman MF, Van Groeningen CJ, Nieboer C, et al.: Linear IgA bullous dermatosis in a patient with renal cell carcinoma.
(99.) Billet SE, Kortuem KR, Gibson LE, El-Azhary R: A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis. Arch Dermatol 2008;144:774-8.